Clinical Trials Directory

Trials / Completed

CompletedNCT01507493

The Impact of SCN9A Gene Polymorphism on Individual Pain Perception in the General Population

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Xianwei Zhang · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study was conducted to explore whether the non-synonymous single-nucleotide polymorphisms in SCN9A gene can predict individual basal pain perception and postoperative pain intensity in the general population undergoing upper abdominal surgery. Methods: Patients receiving elective upper abdominal surgery under general anesthesia were recruited into this study. Genotyping of SCN9A was carried out by direct sequencing. The investigators measured their preoperative pressure pain threshold (PPT) and pressure pain tolerance (PTO). The visual analog scale (VAS) was used for pain evaluation at rest during patient-controlled analgesia (PCA) treatment 0 h, 12 h ,24 h and 48h after operation. And the PCA press frequency and drug consumption were recorded.

Detailed description

Patients with the following diseases were excluded: known history of chronic pain, psychiatric diseases or communication disorders, diabetes mellitus, severe cardiovascular diseases, kidney or liver diseases with poor hepatic function, alcohol or drug abuse, heavy smoker, pregnancy or at the lactation period.

Conditions

Timeline

Start date
2011-01-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2012-01-11
Last updated
2014-09-03
Results posted
2014-09-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01507493. Inclusion in this directory is not an endorsement.

The Impact of SCN9A Gene Polymorphism on Individual Pain Perception in the General Population (NCT01507493) · Clinical Trials Directory